Related Experiment Videos
[Psychiatric problems in internal practice. Part I]
1Psychiatrická klinika LF MU a FN, Brno-Bohunice. eceska@med.muni.cz
Insights
Depression is common in cardiovascular disease patients, increasing morbidity and mortality. New antidepressants with fewer cardiovascular effects offer promising treatment options for these complex cases.
Area of Science:
- Cardiology
- Psychiatry
- Internal Medicine
Context:
- Depression frequently co-occurs with cardiovascular disease (CVD).
- Cardiovascular complications significantly contribute to morbidity and mortality in depressed patients.
- Shared etiopathogenic factors link depression and CVD, including endocrine, immune, personality, and lifestyle elements.
Purpose:
- To review the complex relationship between depression and cardiovascular disease.
- To highlight diagnostic challenges of depression in medically ill patients.
- To explore potential treatment strategies and the role of novel pharmacotherapies.
Summary:
- Depression is a significant comorbidity in cardiovascular disease, exacerbating patient outcomes.
- Identifying depression in patients with somatic diseases can be challenging but is crucial.
- Emerging antidepressant medications with reduced cardiovascular impact show promise for internal medicine settings.
Impact:
- Underscores the need for integrated care approaches in managing comorbid depression and CVD.
- Highlights the potential of new pharmacological treatments to improve patient prognosis.
- Emphasizes the importance of interdisciplinary collaboration between cardiologists, psychiatrists, and internists.
Abstract:
Review deals with depression, which frequently occurs in patients with cardiovascular disease. Along with that, cardiovascular complications are frequent cause of the high morbidity and mortality of depressed patients. Several common ethiopathogenic factors can be identified (endocrine changes, immunity alteration, structure of personality, life style). Diagnose of depression in somatically diseased patients may be difficult to set; however, it is necessary to consider it. Some conjoint treatment approaches are possible. For the use in the internal medicine new antidepression drugs with lower affects on the cardiovascular system appear promising. Mutual collaboration in the clinical praxis is highly desirable.